Your Cart is Empty
(NEW SIZE!) Acidophilus, 90 caps
$ 22.50
| Qty | Discount |
|---|---|
| Buy 3 | 3% Off |
| Buy 5 | 5% Off |
Free Shipping On Orders over $50
Nutritionist Approved
60-Day Return Guarantee
DESCRIPTION
NutriKey Acidophilus is using the NCFM® strain and has 2.5 billion CFU’s per capsule. This pure strain of Lactobacillus acidophilus helps maintain a healthy balance of intestinal flora and has broad intestinal, digestive, and immune system support functions.
INGREDIENTS
Serving Size: 1 capsule
Servings per Container: 90
Pill Size: #3 Veggie Cap
Ingredients: Lactobacillus acidophilus UALa-01™ 2.5 Billion CFU
Other Ingredients: Microcrystalline cellulose, hypromellose, vegetable magnesium stearate, silica.
Gluten Free | Dairy Free | Non-GMO | Vegetarian | Vegan
All NutriKey brand supplements are Pharmaceutical Grade and produced in Certified GMP (cGMP) facilities. All NutriKey brand supplements meet or exceed cGMP standards and are third party tested.
*UALa-01™ is a trademark of Chr. Hansen
DIRECTIONS
Directions: 1-2 capsules at night or if extreme symptoms can take 1-2 caps before meals.
Note: If you are a new probiotic user we recommend to start slow and build up to the full dose. Jump down to the Learn More section for more info.
Storage: Store in a cool, dry place.
LEARN MORE
Lactobacillus acidophilus NCFM®L. acidophilus NCFM®, which stands for the research laboratory it was first discovered at (“North Carolina Food Microbiology” lab), is a patented beneficial lactic acid bacteria strain often used to support lactose intolerance by promoting the digestion of simple sugars and other tough-to-digest nutrients.
This strain has been shown in numerous studies to help relieve gastrointestinal discomfort by supporting a healthy balance of “friendly” intestinal microbiota. Further research suggests that L. acidophilus NCFM® may activate endocannabinoid and μ-opioid receptors in epithelial cells. These receptors work to modulate pain signals in targeted tissues. L. acidophilus NCFM® is also necessary for helping the body synthesize vitamin B9 (folate) and vitamin B12, which are key for healthy nervous system function.
Why should I start slow when taking a probiotic?
Killing off harmful bacteria in your gut is one of the benefits of probiotics. You may not feel well when you first start taking probiotics because, as it dies, the harmful bacteria will release toxins in your body. This is known as a "die off reaction" or Herxheimer Reaction. Common symptoms of die off are diarrhea, bloating, and headache. As your body is working to flush out the dead bacteria and toxins, it can feel as if your symptoms are temporarily getting worse, which can be alarming, but it does get better! Symptoms go away as the toxins are flushed out and as you build up your healthy gut bacteria. We recommend starting slow when first taking probiotics to minimize die off symptoms.
Statements contained herein have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.
References
1. Evans, J. M., Morris, L. S., & Marchesi, J. R. (2013). The gut microbiome: the role of a virtual organ in the endocrinology of the host. Journal of Endocrinology, 218(3), R37-R47.
2. Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011). Human nutrition, the gut microbiome and the immune system. Nature, 474(7351), 327-336.
3. Turnbaugh, P. J., & Gordon, J. I. (2009). The core gut microbiome, energy balance and obesity. The Journal of physiology, 587(17), 4153-4158.
4. Whelan, K., & Quigley, E. M. (2013). Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Current opinion in gastroenterology, 29(2), 184-189.
2. Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011). Human nutrition, the gut microbiome and the immune system. Nature, 474(7351), 327-336.
3. Turnbaugh, P. J., & Gordon, J. I. (2009). The core gut microbiome, energy balance and obesity. The Journal of physiology, 587(17), 4153-4158.
4. Whelan, K., & Quigley, E. M. (2013). Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Current opinion in gastroenterology, 29(2), 184-189.